µ¼Ê¦ÐÕÃû£ºËïÃ÷ÖÒ?
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º38
ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£º»ù´¡Ò½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º 1.Ö×Áö×ªÒÆ·Ö×Ó»úÖÆ¼°ÁÙ´²Ïà¹ØÐÔÑо¿£»2.Éß¶¾µ°°×ÉúÎï»îÐÔ¼°Ó¦ÓÃÑо¿¡£
Ñо¿ÁìÓò£º 1.Ö×Áö×ªÒÆ·Ö×Ó»úÖÆ¼°ÁÙ´²Ïà¹ØÐÔÑо¿£»2.Éß¶¾µ°°×ÉúÎï»îÐÔ¼°Ó¦ÓÃÑо¿¡£ [ÊÕÆð]
ͨѶ·½Ê½ :
°ì¹«µç»°£º**/**
µç×ÓÓʼþ£ºsmzlsq@163.com
¸öÈ˼òÊö :
ËïÃ÷ÖÒ£¬²©Ê¿£¬½ÌÊÚ£¬Ë¶Ê¿/²©Ê¿Éúµ¼Ê¦,ÏÖÈδóÁ¬Ò½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÉúÎï¼¼Êõϵ½ÌÊÚ£¬Ð£Ñ§¿Æ½¨Éè´¦¸±´¦³¤¡£1999Äê±ÏÒµÓÚÖйú¿ÆÑ§Ôº³¤´ºÓ¦Óû¯Ñ§Ñо¿Ëù£¬Ë¶²©Áª¶Á£¬»ñµÃÀíѧ²©Ê¿Ñ§Î»¡£2000.2- 2007.3£¬ÏȺóÔÚ·¨¹ú¿ÆÑ§Ôº¡¢ÃÀ¹ú°®Òò˹̹ҽѧԺ¡¢ÃÀ¹ú¿Ë¹Î÷±£ÁôµØµÈ´óѧ½øÐпÆÑ§Ñо¿¹¤×÷¡£2007Äê»ñÁÉÄþÊ¡¡°°ÙǧÍòÈ˲ʤ³Ì¡±Ñ§Õ߳ƺţ¬2010.11-11.5£¬Å£½ò´óѧ·ÃÎÊѧÕß¡£ÏÖΪ´óÁ¬Ò½Ñ§»áÉú»¯×¨¿Æ·Ö»áίԱ¡¢´óÁ¬Ò½Ñ§»áҽѧ¹¤³Ìר¿Æ·Ö»áίԱ¡¢´óÁ¬Ò½¿Æ´óѧѧÊõίԱίԱ¡£ÒÑ·¢±íÎÄÕÂ123ƪ£¬ÆäÖÐSCIÎÄÕÂ75ƪ¡£
¿ÆÑй¤×÷ :
³Ðµ£µÄ¹ú¼Ò¼¶ÏîÄ¿£º£¨½ü5Ä꣩1.¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð(**), ceRNAµ÷¿ØmiR-330-3p¡¢EregÔÚÖ×ÁöÁܰ͵À×ªÒÆÖеÄ×÷ÓûúÖÆ¼°ÁÙ´²Ïà¹ØÐÔÑо¿,53ÍòÔª, 2017.1-2020.12,ÏîÄ¿¸ºÔðÈË£»2.¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð(**), Anxa3,Anxa5,Anxa11µ÷¿ØÖ×Áöϸ°ûÁܰ͵À×ªÒÆÁ¦/Ô¤¾¯Ö×Áö×ªÒÆ¼°Æä¹²Ïà¹Øµ°°×Ñо¿,55ÍòÔª£¬2012.1-2015.12£¬ÏîÄ¿¸ºÔðÈË£»
´ú±íÐÔÂÛÎÄ£¨½ü5Ä꣩£º1.Xujuan Sun, Bin Wei, Shuqing Liu, Chunmei Guo, Na Wu, Qinlong Liu, Ming-Zhong Sun. Anxa5 mediates in vitro malignant behaviours of murine hepatocarcinoma Hca-F cells with high lymph node metastasis potential preferentially via ERK2/p-ERK2/c-Jun/p-c-Jun(Ser73) and E-cadherin. Biomedicine & Pharmacotherapy,2016 , 84: 645-654(ͨѶ×÷Õß).
2.Shuqing Liu, Chunmei Guo, Jiasheng Wang, Bo Wang, Houbao Qi, Ming-Zhong Sun. ANXA11 regulates the tumorigenesis, lymph node metastasis and 5-fluorouracil sensitivity of murine hepatocarcinoma Hca-P cells by targeting c-Jun. Oncotarget, 2016,7(13):16297- 16310 (ͨѶ×÷Õß).
3.Boya Peng, Shuqing Liu, Chunmei Guo,Xujuan Sun, Ming-Zhong Sun. ANXA5 level is linked to in vitro and in vivo tumor malignancy and lymphatic metastasis of murine hepatocarcinoma cell. Future Oncology.2015, 12(1): 31-42. (ͨѶ×÷Õß).
4.Chunmei Guo, Shuqing Liu, Panpan Dong, Dongting Zhao, Chengyi Wang, Zhiwei Tao & Ming-Zhong Sun. Akbu-LAAO exhibits potent anti-tumor activity to HepG2 cells partially through produced H2O2 via TGF-¦Â signal pathway. Scientific Reports. 2015, 5:18215. (ͨѶ×÷Õß).
5.Houbao Qi, Shuqing Liu, Chunmei Guo, Jiasheng Wang, Frederick T Greenaway, Ming- Zhong Sun. Role of AnxA6 in cancers. Oncology Letters, 2015, 10: 1947-1952. (ͨѶ×÷Õß).
6.Ming-Zhong Sun, Yanhua Cui, Chunmei Guo, Baochang Zhao, Shuqing Liu. rAdinbitor, a disintegrin from Agkistrodon halys brevicaudus stejneger, inhibits tumorigenicity of hepatocarcinoma via enhanced anti-angiogenesis and immunocompetence. Biochimie, 2015, 116: 34-52 (µÚÒ»×÷Õß) .
7.Bin Wei, Chunmei Guo, Shuqing Liu, Ming-Zhong Sun. Annexin A4 and cancer. Clin Chim Acta, 2015, 447: 72-78 (ͨѶ×÷Õß).
8.Ji Shi, Longlong Meng, Ming-Zhong Sun, Chunmei Guo , Xujuan Sun, Qiuyue Lin, Shuqing Liu.CRKL knockdown promotes in vitro proliferation, migration and invasion, in vivo tumor malignancy and lymph node metastasis of murine hepatocarcinoma Hca-P cells. Biomedicine & Pharmacotherapy 2015, 71: 84-90 (ͨѶ×÷Õß).
9.Shuqing Liu, Jiasheng Wang, Chunmei Guo, Houbao Qi, Ming-Zhong Sun. Annexin A11 knockdown inhibits in vitro proliferation and enhances survival of Hca-F cell via Akt2/FoxO1 pathway and MMP-9 expression. Biomedicine & Pharmacotherapy, 2015, 70: 58-63 (ͨѶ×÷Õß).
10.Chunmei Guo, Shuqing Liu, Ming-Zhong Sun. The role of CT10 regulation of kinase-like in cancer. CRKL in cancer. Future Oncology, 2014, 10(16): 2687-2697. (ͨѶ×÷Õß).
11.Shuqing Liu, Chunmei Guo , Yimeng Guo,, Hongshan Yu, Frederick Greenaway, Ming-Zhong Sun. Comparative binding affinities of flavonoid phytochemicals with bovine serum albumin. Iranian Journal of Pharmaceutical Research, 2014, 13(3): 1019-1028. (ͨѶ×÷Õß).
12.Jiasheng Wang, Chunmei Guo, Shuqing Liu, Houbao Qi, Yuling Yin, Rui Liang, Ming-Zhong Sun, Frederick Greenaway. Annexin A11 in disease. Clin Chim Acta,2014,431: 164-168. (ͨѶ×÷Õß).
13.Boya Peng, Chunmei Guo, Hongwei Guan, Shuqing Liu, Ming-Zhong Sun. Annexin A5 as a potential marker in tumors. Clin Chim Acta, 2014, 427:42-48. (ͨѶ×÷Õß).
14.Chunmei Guo, Shuqing Liu, Ming-Zhong Sun. Potential role of Anxa1 in cancer. Future Oncology, 2013, 9(11): 1773-1793. (ͨѶ×÷Õß).
15.Chunmei Guo, Shuqing Liu, Frederick Greenaway, Ming-Zhong Sun. Potential role of annexin A7 in cancers. Clin Chim Acta, 2013, 423: 83-89. (ͨѶ×÷Õß)
16.Chunmei Guo, Shuqing Liu, Ming-Zhong Sun. Sequence and bioinformatic characterization of ESTs originated from Gloydius shedaoensis shedaoensis venom gland. The Anatomical Record, 2013, 296: 807-814. (ͨѶ×÷Õß)
½ÌÓý±³¾° :
1994Äê9ÔÂ-1999Äê12Ô£¬Öйú¿ÆÑ§Ôº³¤´ºÓ¦Óû¯Ñ§Ñо¿Ëù£¬ÎÞ»ú»¯Ñ§£¬Àíѧ²©Ê¿(˶²©Á¬¶Á)£¬µ¼Ê¦: Äß¼ÎçÚԺʿ£»1990Äê9ÔÂ-1994Äê7Ô£¬ÁijÇʦ·¶Ñ§Ôº£¬»¯Ñ§Ïµ£¬»¯Ñ§½ÌÓý£¬Àíѧѧʿ¡£
´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ËïÃ÷ÖÒ?
±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-05-27
Ïà¹Ø»°Ìâ/Ö×Áö ÁÙ´² Àíѧ µ¼Ê¦ ´óÁ¬Ò½¿Æ´óѧ
´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕÅ΢
µ¼Ê¦ÐÕÃû£ºÕÅ΢ÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÀÏÄêÐÄÄÔѪ¹Ü¼²²¡µÄÁÙ´²Óë»ù´¡Ñо¿Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÀÏÄêÐÄÄÔѪ¹Ü¼²²¡µÄÁÙ´²Óë»ù´¡Ñо¿[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºzhangwei2682@163.com¸öÈ˼òÊö:ÕÅ΢ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-³Ã÷
µ¼Ê¦ÐÕÃû£ºÂ³Ã÷ÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÑо¿·½ÏòΪËÄÖ«´´ÃæµÄÉúÎï»úеÖÎÁÆÑо¿ÁìÓò£ºÖ÷ÒªÑо¿·½ÏòΪËÄÖ«´´ÃæµÄÉúÎï»úеÖÎÁÆ[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºdllm@2008.sina.com¸öÈ˼òÊö:³Ã÷£¬²©Ê¿£¬¸±½ÌÊÚ£¬ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÐÏÙ»
µ¼Ê¦ÐÕÃû£ºÐÏÙ»ÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º×ÔÉíÃâÒßÐÔ¼××´ÏÙ¼²²¡µÄ·¢²¡»úÖÆ¡¢ÈÑÉïÆÚ¼××´ÏÙ¼²²¡¶ÔÔи¾¼°Ì¥¶ùµÄÓ°Ïì¡¢¼××´ÏÙ¼¤ËصÄ×÷Óá£Ñо¿ÁìÓò£º×ÔÉíÃâÒßÐÔ¼××´ÏÙ¼²²¡µÄ·¢²¡»úÖÆ¡¢ÈÑÉïÆÚ¼××´ÏÙ¼²²¡¶ÔÔи¾¼°Ì¥¶ùµÄÓ°Ïì¡¢¼××´ÏÙ¼¤ËØµÄ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÂÀ÷
µ¼Ê¦ÐÕÃû£ºÂÀ÷ÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£ºÖ÷ÈÎҽʦµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÒ»£®Í·¾±²¿Ö×ÁöµÄÕï¶Ï¡¢ÖÎÁƼ°Ñо¿£¬Ö÷Òª°üÀ¨£º1£®ºí°©ºÍºíÑʰ©ÌåÄÚ¡¢ÍâÉú³¤¼°»ùÒò±í´ï²îÒìµÄÑÐ...[Õ¹¿ª]Ñо¿ÁìÓò£ºÒ»£®Í·¾±²¿Ö×ÁöµÄÕï¶Ï¡¢ÖÎÁƼ°Ñо¿£¬Ö÷Òª°üÀ¨£º1£®ºí°©ºÍºíÑʰ©Ìå ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-½¯Àö
µ¼Ê¦ÐÕÃû£º½¯ÀöÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚŧ¶¾Ö¢ÁÙ´²ÆÀ¼ÛϵͳÒÔ¼°¸÷ÖÖÖж¾»úÖÆµÄÑо¿£¬·¢ÏÖÖÂËÀÐÔ¶¾ÎïµÄ×îÐÂÖÎÁÆ·½·¨¡£Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚŧ¶¾Ö¢ÁÙ´²ÆÀ¼ÛϵͳÒÔ¼°¸÷ÖÖÖж¾»úÖÆµÄÑо¿£¬·¢ÏÖÖÂËÀÐÔ¶¾ÎïµÄ×îÐÂÖÎÁÆ·½·¨¡£[ÊÕ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÀîÕæ
µ¼Ê¦ÐÕÃû£ºÀîÕæÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÉó¤¶ÔÐÄѪ¹Ü²¡¼±ÖØÖ¢µÄÕïÖΣ¬ÕÆÎÕÓÀ¾ÃÆð²«Æ÷Ö²Èë¼¼Êõ£¬¶ÔÀÏÄê×ÛºÏÕ÷¼°ÀÏÄê³£¼ûÎÊÌâµÄÁÙ´²ÆÀ¹ÀºÍ...[Õ¹¿ª]Ñо¿ÁìÓò£ºÉó¤¶ÔÐÄѪ¹Ü²¡¼±ÖØÖ¢µÄÕïÖΣ¬ÕÆÎÕÓÀ¾ÃÆð²«Æ÷Ö²Èë¼¼Êõ£¬¶ÔÀÏÄê×ÛºÏÕ÷¼°ÀÏ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÓÚÏþºç
µ¼Ê¦ÐÕÃû£ºÓÚÏþºçÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£ºÖ÷ÈÎҽʦµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÆ¤·ôÕæ¾ú²¡ºÍÐÔ²¡µÄÑо¿¡£Ñо¿·½Ïò°üÀ¨£ºÖ²¡Õæ¾úµÄ»ùÒò¼ø¶¨µÄÁÙ´²Ó¦ÓúÍÒâÒ壻Ö²¡Õæ...[Õ¹¿ª]Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÆ¤·ôÕæ¾ú²¡ºÍÐÔ²¡µÄÑо¿¡£Ñо¿·½Ïò°üÀ¨£ºÖ²¡Õæ¾úµÄ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Õž¸»ª
µ¼Ê¦ÐÕÃû£ºÕž¸»ªÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º×ãϸ°ûÓëÉöСÇò¼²²¡Ñо¿ÁìÓò£º×ãϸ°ûÓëÉöСÇò¼²²¡[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºzhangjinghuadl@163.com¸öÈ˼òÊö:Õž¸»ª£¬Å®£¬¸±½ÌÊÚ£¬Ë¶Ê¿Éúµ¼Ê¦£¬¸±Ö÷ÈÎҽʦ£¬Ò½ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Ö£ÏþÓ¢
µ¼Ê¦ÐÕÃû£ºÖ£ÏþÓ¢ÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÂýÐÔ×èÈûÐԷμ²²¡¡¢Ö§Æø¹ÜÏø´¡¢Ë¯ÃߺôÎü¼²²¡¡¢¼äÖÊÐԷμ²²¡µÈ£»ÑªÇå×ÜIgEÓëÂý×è·Î+Ïø´£¨ÖØ...[Õ¹¿ª]Ñо¿ÁìÓò£ºÂýÐÔ×èÈûÐԷμ²²¡¡¢Ö§Æø¹ÜÏø´¡¢Ë¯ÃߺôÎü¼²²¡¡¢¼äÖÊÐԷμ²²¡µÈ£»Ñª ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Àîì¿Áá
µ¼Ê¦ÐÕÃû£ºÀîì¿ÁáÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£º»ù´¡Ò½Ñ§ÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÖ×ÁöÐγɺÍÄÍÒ©ÐÔ»úÖÆµÄÑо¿¡£Ñо¿·½Ïò°üÀ¨£ºÁ×ËữøÔÚÖ×Áö·¢Éú·¢Õ¹¹ý³ÌÖÐ×÷Ó㻣ģÎ...[Õ¹¿ª]Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÖ×ÁöÐγɺÍÄÍÒ©ÐÔ»úÖÆµÄÑо¿¡£Ñо¿·½Ïò°üÀ¨£ºÁ×ËữøÔÚ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-¶´º²¨
µ¼Ê¦ÐÕÃû£º¶´º²¨ÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÀÏÄê³Õ´ôµÄÔçÆÚÕï¶Ï¡¢¼ø±ðÕï¶Ï¼°ÖÎÁÆ2.ÖÐÊàÉñ¾ÏµÍ³ÒÅ´«²¡£¨SCA£©3.Ô˶¯Õϰ£¨MSA£©£º...[Õ¹¿ª]Ñо¿ÁìÓò£ºÀÏÄê³Õ´ôµÄÔçÆÚÕï¶Ï¡¢¼ø±ðÕï¶Ï¼°ÖÎÁÆ2.ÖÐÊàÉñ¾ÏµÍ³ÒÅ´«²¡£¨SC ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÁõÀö÷
µ¼Ê¦ÐÕÃû£ºÁõÀö÷ÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚ¶þÁÙ´²Ñ§ÔºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º¸öÈ˼òÊö:ÁõÀö÷ÓÚ1993Äê±¾¿Æ±ÏÒµÓÚÉϺ£Ò½¿Æ´óѧ£¨ÏÖ¸üÃûΪ¸´µ©´óѧҽѧԺ£©ÁÙ´²Ò½Ñ§öλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬¹¤×÷ÓÚ´óÁ¬Ò½¿Æ´óѧ¸½ÊôµÚ¶þÒ½ÔºÉñ¾ÄÚ¿Æ£¬¹¤×÷ÖÁ½ñ¡£2001Äê˶ʿ±ÏÒµÓÚ´óÁ¬Ò½¿Æ´óѧ¡£2010Äê½úÉýΪÖ÷ÈÎ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-¹ùΰ
µ¼Ê¦ÐÕÃû£º¹ùΰÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÆ¤·ôÁ¼¶ñÐÔÖ×ÁöµÄÑо¿°üÀ¨²¡Òò¡¢·¢²¡»úÀíµÄÑо¿£¬Õï¶Ï¼°ÖÎÁƽøÕ¹µÄÑо¿£¬»ùµ×ϸ°û°©µÄ...[Õ¹¿ª]Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÆ¤·ôÁ¼¶ñÐÔÖ×ÁöµÄÑо¿°üÀ¨²¡Òò¡¢·¢²¡»úÀíµÄÑо¿£¬Õï¶Ï¼°ÖÎ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÁõÎÄÖ¾
µ¼Ê¦ÐÕÃû£ºÁõÎÄÖ¾ÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÉó¤Î¸³¦µÀÖ×ÁöµÄÕï¶Ï¼°×ÛºÏÖÎÁÆ£¬ÊìÁ·ÕÆÎÕÆÕͨÍâ¿Æ³£¼û²¡¡¢¶à·¢²¡µÄÕïÖΣ¬¶Ô¼±¸¹Ö¢¼°ÆÕÍâÒÉÄÑΣ...[Õ¹¿ª]Ñо¿ÁìÓò£ºÉó¤Î¸³¦µÀÖ×ÁöµÄÕï¶Ï¼°×ÛºÏÖÎÁÆ£¬ÊìÁ·ÕÆÎÕÆÕͨÍâ¿Æ³£¼û²¡¡¢¶à·¢²¡µÄÕïÖΣ¬¶Ô¼± ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÆÓÏèÓî
µ¼Ê¦ÐÕÃû£ºÆÓÏèÓîÐÔ±ð£ºÈËÆøÖ¸Êý£º38ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÄÔѪ¹Ü²¡¡¢Éñ¾ÍËÐÐÐÔ¼²²¡µÄ²¡Òò¼°Æä·¢²¡»úÖÆ¡¢ÖÎÁƼ°ÔçÆÚÔ¤·ÀµÄÑо¿Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÄÔѪ¹Ü²¡¡¢Éñ¾ÍËÐÐÐÔ¼²²¡µÄ²¡Òò¼°Æä·¢²¡»úÖÆ¡¢ÖÎÁƼ°ÔçÆÚÔ¤·ÀµÄÑо¿[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºp ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
